368 related articles for article (PubMed ID: 17653732)
21. Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodies.
Kalaitzakis ME; Pearce RK; Gentleman SM
Neurosci Lett; 2009 Sep; 461(1):12-5. PubMed ID: 19523504
[TBL] [Abstract][Full Text] [Related]
22. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease.
Hou X; Fiesel FC; Truban D; Castanedes Casey M; Lin WL; Soto AI; Tacik P; Rousseau LG; Diehl NN; Heckman MG; Lorenzo-Betancor O; Ferrer I; Arbelo JM; Steele JC; Farrer MJ; Cornejo-Olivas M; Torres L; Mata IF; Graff-Radford NR; Wszolek ZK; Ross OA; Murray ME; Dickson DW; Springer W
Autophagy; 2018; 14(8):1404-1418. PubMed ID: 29947276
[TBL] [Abstract][Full Text] [Related]
23. Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies.
Kasanuki K; Iseki E; Kondo D; Fujishiro H; Minegishi M; Sato K; Katsuse O; Hino H; Kosaka K; Arai H
Neurosci Lett; 2014 May; 569():68-73. PubMed ID: 24704327
[TBL] [Abstract][Full Text] [Related]
24. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
Deramecourt V; Bombois S; Maurage CA; Ghestem A; Drobecq H; Vanmechelen E; Lebert F; Pasquier F; Delacourte A
J Neuropathol Exp Neurol; 2006 Mar; 65(3):278-88. PubMed ID: 16651889
[TBL] [Abstract][Full Text] [Related]
25. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.
Galvin JE; Uryu K; Lee VM; Trojanowski JQ
Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13450-5. PubMed ID: 10557341
[TBL] [Abstract][Full Text] [Related]
26. Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease.
Brandmeir NJ; Geser F; Kwong LK; Zimmerman E; Qian J; Lee VM; Trojanowski JQ
Acta Neuropathol; 2008 Jan; 115(1):123-31. PubMed ID: 18004574
[TBL] [Abstract][Full Text] [Related]
27. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
[TBL] [Abstract][Full Text] [Related]
29. TDP-43 pathology in familial British dementia.
Schwab C; Arai T; Hasegawa M; Akiyama H; Yu S; McGeer PL
Acta Neuropathol; 2009 Aug; 118(2):303-11. PubMed ID: 19283396
[TBL] [Abstract][Full Text] [Related]
30. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
31. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders.
Gelpi E; Navarro-Otano J; Tolosa E; Gaig C; Compta Y; Rey MJ; Martí MJ; Hernández I; Valldeoriola F; Reñé R; Ribalta T
Mov Disord; 2014 Jul; 29(8):1010-8. PubMed ID: 24395122
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
Jellinger KA; Attems J
Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
[TBL] [Abstract][Full Text] [Related]
33. Synucleinopathies: common features and hippocampal manifestations.
Yang W; Yu S
Cell Mol Life Sci; 2017 Apr; 74(8):1485-1501. PubMed ID: 27826641
[TBL] [Abstract][Full Text] [Related]
34. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia.
Zhang H; Tan CF; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
Acta Neuropathol; 2008 Jan; 115(1):115-22. PubMed ID: 17786458
[TBL] [Abstract][Full Text] [Related]
35. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A.
Aoki N; Murray ME; Ogaki K; Fujioka S; Rutherford NJ; Rademakers R; Ross OA; Dickson DW
Acta Neuropathol; 2015 Jan; 129(1):53-64. PubMed ID: 25367383
[TBL] [Abstract][Full Text] [Related]
36. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
37. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical localization of spatacsin in α-synucleinopathies.
Kuru S; Yoshida M; Tatsumi S; Mimuro M
Neuropathology; 2014 Apr; 34(2):135-9. PubMed ID: 24112408
[TBL] [Abstract][Full Text] [Related]
39. Significance and limitation of the pathological classification of TDP-43 proteinopathy.
Arai T
Neuropathology; 2014 Dec; 34(6):578-88. PubMed ID: 25196969
[TBL] [Abstract][Full Text] [Related]
40. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions.
Mackenzie IR; Foti D; Woulfe J; Hurwitz TA
Brain; 2008 May; 131(Pt 5):1282-93. PubMed ID: 18362096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
